Search clinical trials for: rhIL-15

Total 1073 results

Centre Hospitalier Universitaire Dijon

Unknown

Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours (GAMETH)

Seminomas

France
Hadassah Medical Organization

Terminated

TSO in Pediatric Autistic Spectrum Disorders (TSO)

Autistic Spectrum Disorders

Israel
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial With Influenza A/H1N1 Vaccines

Influenza

China
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Fasting

Healthy

United States
Sheba Medical Center

Unknown

A Prospective Study of Misoprostol Administration in Asymptomatic Patients With Pregnancies of Unknown Location (amalis)

Pregnancies of Unknown Location (PUL)
Ferring Pharmaceuticals

Completed

LutrePulse Hypogonadotropic Hypogonadism

Primary Amenorrhea With Hypogonadotropic Hypogonadism

United States, Canada
Ottawa Heart Institute Research Corporation

Recruiting

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)

Radial Artery Occlusion

Canada
Youssef Daali

Completed

Use of Endogenous Melatonin and 6-hydroxymelatonin as Biomarkers for CYP1A2 (MelaCYP)

Healthy

Switzerland
University Medical Centre Ljubljana
Institute of Oncology Ljubljana

Terminated

Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study) (PanECT)

Pancreas Cancer

Slovenia
Centre Hospitalier Universitaire Dijon

Recruiting

Effects of Eccentric Pedaling at Different Rates on Neuromuscular Function (Exo-Mode 3)

Volunteers Who Can do Moderate Physical Activity

France
Rajaie Cardiovascular Medical and Research Center
National Institute for Medical research and Development (NIMAD); Abidi Pharmaceuticals

Terminated

RIvoraxaban in Mitral Stenosis (RISE MS)

Atrial Fibrillation | Rheumatic Heart Disease | Mitral Stenosis | Anticoagulant Adverse Reaction

Iran, Islamic Republic of
Janssen Research & Development, LLC
Bayer

Completed

A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis

End-Stage Renal Disease

United States
University of Patras

Completed

Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease

Coronary Artery Disease | Endothelial Function

Greece
Hvivo
GlaxoSmithKline

Completed

Development of an Intranasal Proteosome Influenza Vaccine

Influenza
Memorial Sloan Kettering Cancer Center
Y-mAbs Therapeutics

Active, not recruiting

Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Neuroblastoma | High-Risk

United States
Novo Nordisk A/S

Completed

Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer

Cancer | Ovarian Cancer

Germany, France
Alaunos Therapeutics

Completed

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.

Breast Cancer Nos Metastatic Recurrent

United States
Novartis Pharmaceuticals

Completed

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

Chronic Myelogenous Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Germany, Australia, Netherlands, Spain, Korea, Republic of, France, Japan, Italy, Singapore, United States
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers

Healthy
Novo Nordisk A/S

Completed

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Atherosclerotic Cardiovascular Disease

Germany, Poland, United States, Netherlands, Japan, Greece, Belgium
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Terminated

Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers

Electronic Cigarettes

United States
Glasgow Caledonian University
University of Strathclyde

Unknown

Role of Interrupting Sedentary Time in Management of Type-2 Diabetes (Just_StandUp)

Diabetes
Universidad del Desarrollo
Technical University of Munich

Recruiting

Re-evaluation of the Effect Site Model of the PKPD Propofol Eleveld Model (Eleved PD)

Healthy | Surgery

Chile
Assistance Publique - Hôpitaux de Paris
Hoffmann-La Roche

Completed

Rituximab in Auto-Immune Hemolytic Anemia (RAHIA)

Warm Autoimmune Hemolytic Anemia

France
United States Department of Defense
GlaxoSmithKline

Unknown

Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders

Depression | Mood Disorders | Combat Disorders | Stress Disorders

Iraq
Shanghai Institute Of Biological Products

Completed

Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants

Influenza

China
AHS Cancer Control Alberta

Recruiting

Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients

Glioblastoma Multiforme

Canada
Bayer

Completed

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. (RECORD 3)

Venous Thromboembolism | Prevention

Belgium, Italy, Poland, Spain, China, France, Denmark, Netherlands, Austria, Germany, Mexico, South Africa, Sweden, Colombia, Israel, Canada, Norway, Peru, Czech Republic
Hillerod Hospital, Denmark
Wyeth is now a wholly owned subsidiary of Pfizer; Tvergaards Foundation

Terminated

Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression

Major Depression

Denmark
Rutgers, The State University of New Jersey

Terminated

Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19

COVID-19 | SARS-CoV-2

United States
Athenex, Inc.

Completed

A PK Study of Oraxol in Breast Cancer Patients

Breastcancer

China
MorphoSys AG
Clinigen Healthcare Ltd

Approved for marketing

Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL

DLBCL
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Prescription Opioid Effects in Abusers Versus Non-Abusers

Substance-Related Disorders | Opioid-Related Disorders

United States
Takeda

Completed

Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

Gastric or Duodenal Ulcers
UNC Lineberger Comprehensive Cancer Center
United States Department of Defense; Bellicum Pharmaceuticals; University Cancer...

Recruiting

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Osteosarcoma | Neuroblastoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer | KRAS Gene Mutation

United States
University of Split, School of Medicine

Completed

Cytogenetic Damage in Buccal Cells Caused by Toothpaste

Toxicity
Boehringer Ingelheim

Completed

BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment

Leukemia, Myeloid, Acute

Germany
Merck Sharp & Dohme LLC

Completed

A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)

Rheumatoid Arthritis
Samsung Medical Center

Completed

Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty

Femur Head Necrosis | Osteoarthritis, Hip | Femoral Neck Fractures
AcelRx Pharmaceuticals, Inc.

Completed

An Open-Label Functionality, Safety and Efficacy Study in Patients Undergoing Elective Unilateral Knee Replacement

Pain, Postoperative

United States
Onze Lieve Vrouwe Gasthuis
Medela AG

Completed

Assessing the Effect of an Additional 5 Minutes Pumping on Milk Output in the First Days After Delivery

Breast Pumping

Netherlands
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Center for Outcomes...

Suspended

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

COVID-19 | Corona Virus Infection | SARS-CoV-2 | 2019-nCoV | 2019 Novel Coronavirus

United States
Shanghai Institute Of Biological Products

Completed

The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine

Influenza

China
Translational Oncology Research International
Genentech, Inc.

Completed

Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299)

Breast Cancer

Canada, United States, Ireland
GlaxoSmithKline

Terminated

Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza

Virus Diseases

United States, Sweden, Russian Federation, Romania
Centre Hospitalier Universitaire de Saint Etienne
Bayer

Terminated

PROphylaxis in NOn Major Orthopaedic Surgery (PRONOMOS)

Non-major Orthopaedic Surgery

France
Regional Hospital Holstebro
Aarhus University Hospital

Completed

Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA) (DOVA)

Nephropathy

Denmark
Centre of Postgraduate Medical Education

Unknown

Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.

Blood Loss | Hip Osteoarthritis

Poland

Search clinical trials for: rhIL-15

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations